Qingxia Fan

5.3k total citations
111 papers, 2.3k citations indexed

About

Qingxia Fan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qingxia Fan has authored 111 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 49 papers in Molecular Biology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qingxia Fan's work include Gastric Cancer Management and Outcomes (27 papers), Esophageal Cancer Research and Treatment (20 papers) and Cancer-related molecular mechanisms research (16 papers). Qingxia Fan is often cited by papers focused on Gastric Cancer Management and Outcomes (27 papers), Esophageal Cancer Research and Treatment (20 papers) and Cancer-related molecular mechanisms research (16 papers). Qingxia Fan collaborates with scholars based in China, United States and Ethiopia. Qingxia Fan's co-authors include Liuxing Wang, Hong Zong, Yan Sun, Feng Wang, Xu Han, Weijie Zhang, Xinguang Cao, Mingzhi Zhang, Feng Wang and Qingjiang Chen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Qingxia Fan

108 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingxia Fan China 30 1.4k 996 717 486 322 111 2.3k
Qu Cai China 29 1.6k 1.1× 1.2k 1.2× 655 0.9× 410 0.8× 321 1.0× 74 2.4k
Haiyong Wang China 27 867 0.6× 477 0.5× 550 0.8× 370 0.8× 327 1.0× 83 1.8k
Lizong Shen China 26 1.0k 0.7× 471 0.5× 670 0.9× 415 0.9× 429 1.3× 52 1.9k
Xi Jin China 26 1.3k 0.9× 1.0k 1.0× 775 1.1× 668 1.4× 109 0.3× 83 2.5k
Lidong Wang China 30 1.6k 1.1× 589 0.6× 783 1.1× 497 1.0× 934 2.9× 113 2.8k
Hua Xiong China 27 1.4k 1.0× 608 0.6× 882 1.2× 235 0.5× 269 0.8× 52 2.4k
Hongqing Xi China 24 763 0.5× 561 0.6× 543 0.8× 631 1.3× 416 1.3× 81 1.9k
Tasuku Matsuoka Japan 23 789 0.6× 410 0.4× 488 0.7× 434 0.9× 273 0.8× 54 1.5k
Xiaodi Zhao China 24 1.5k 1.0× 1.1k 1.1× 467 0.7× 231 0.5× 183 0.6× 68 2.1k

Countries citing papers authored by Qingxia Fan

Since Specialization
Citations

This map shows the geographic impact of Qingxia Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingxia Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingxia Fan more than expected).

Fields of papers citing papers by Qingxia Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingxia Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingxia Fan. The network helps show where Qingxia Fan may publish in the future.

Co-authorship network of co-authors of Qingxia Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Qingxia Fan. A scholar is included among the top collaborators of Qingxia Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingxia Fan. Qingxia Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Zhengfu, Han Liang, Suxia Luo, et al.. (2025). Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial. Journal for ImmunoTherapy of Cancer. 13(1). e010543–e010543. 3 indexed citations
2.
3.
Meng, Xiangrui, et al.. (2024). Camrelizumab combined with apatinib as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: A phase 2 trial.. Journal of Clinical Oncology. 42(16_suppl). e16087–e16087.
4.
5.
Qin, Shukui, Jiafu Ji, Rui‐Hua Xu, et al.. (2021). Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status: A Noninterventional Registry Study (EVIDENCE). The Oncologist. 26(9). e1567–e1580. 23 indexed citations
6.
Liu, Quan, Minjie Yang, Xiangke Li, et al.. (2020). A study of the mechanism of lncRNA-CR594175 in regulating proliferation and invasion of hepatocellular carcinoma cells in vivo and in vitro. Infectious Agents and Cancer. 15(1). 6 indexed citations
7.
8.
Song, Lijie, Shunli Yu, Yihui Ma, et al.. (2019). Clinical analysis of 547 patients with neuroendocrine tumors in a Chinese population: A single‐center study. Cancer Medicine. 8(8). 3729–3737. 12 indexed citations
9.
10.
Yang, Chengliang, Xiaoli Zheng, Ke Ye, et al.. (2018). NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway. The International Journal of Biochemistry & Cell Biology. 99. 43–51. 20 indexed citations
11.
Yang, Chengliang, Xiaoli Zheng, Ke Ye, et al.. (2018). MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1. Cellular Physiology and Biochemistry. 46(1). 93–106. 37 indexed citations
12.
Wang, Yongling, et al.. (2018). MiR-433-3p Inhibits Proliferation and Invasion of Esophageal Squamous Cell Carcinoma by Targeting GRB2. Cellular Physiology and Biochemistry. 46(5). 2187–2196. 41 indexed citations
13.
Yang, Jing, et al.. (2016). BLCA-4 and UBC combined detection for early diagnosis of bladder cancer.. PubMed. 30(2). 485–90. 2 indexed citations
14.
Huang, Jing, Qingxia Fan, Ping Lu, et al.. (2016). Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study. Journal of Thoracic Oncology. 11(6). 910–917. 55 indexed citations
15.
16.
Gong, Shuai, et al.. (2015). Regulation of NANOG in cancer cells. Molecular Carcinogenesis. 54(9). 679–687. 86 indexed citations
17.
Han, Xu, Mengquan Li, Yue Zhou, et al.. (2015). S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2. Tumor Biology. 37(3). 2925–2932. 31 indexed citations
18.
Wang, Huili, Yuzhou Zhao, Jie Ma, et al.. (2013). Short Communication The genetic variant rs401681C/T is associated with the risk of non-small cell lung cancer in a Chinese mainland population. Genetics and Molecular Research. 12(1). 67–73. 13 indexed citations
19.
Wang, Feng, Shenglei Li, Ke Li, et al.. (2011). Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma. Journal of Surgical Oncology. 103(7). 704–715. 12 indexed citations
20.
Fan, Qingxia, et al.. (2010). Paclitaxel combined with nedaplatin in the treatment of advanced esophageal cancer. Central Plains Medical Journal. 37(9). 25–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qu Cai Breakdown of academic impact, for papers by Haiyong Wang Breakdown of academic impact, for papers by Lizong Shen Breakdown of academic impact, for papers by Xi Jin Breakdown of academic impact, for papers by Lidong Wang Breakdown of academic impact, for papers by Hua Xiong Breakdown of academic impact, for papers by Hongqing Xi Breakdown of academic impact, for papers by Tasuku Matsuoka Breakdown of academic impact, for papers by Xiaodi Zhao
Rankless by CCL
2026